<DOC>
	<DOCNO>NCT00002334</DOCNO>
	<brief_summary>To compare , zidovudine ( AZT ) -naive patient , safety , tolerance , efficacy saquinavir mesylate ( Ro 31-8959 ) alone versus AZT alone versus AZT combination Ro 31-8959 , zalcitabine ( ddC ) , . To compare various disease marker among different regimen .</brief_summary>
	<brief_title>A Study Zidovudine ( AZT ) Used Alone Combination With Other Anti-HIV Drugs HIV-Infected Patients With Little No Previous Treatment</brief_title>
	<detailed_description>Patients randomize receive minimum 80 week AZT alone , AZT plus ddC , AZT plus Ro 31-8959 , three drug .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Zalcitabine</mesh_term>
	<mesh_term>Saquinavir</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Erythropoietin GCSF . Concurrent Treatment : Allowed : Local skin radiotherapy . Patients must : HIV infection . CD4 count 50 350 cells/mm3 . No prior antiretroviral therapy OR le 16 week prior AZT . No acute serious opportunistic infection require immediate treatment . No unexplained fever persist 14 day within 90 day prior study entry . No significant unexplained diarrhea persist 14 day within 30 day prior study entry . No visceral Kaposi 's sarcoma lymphoma currently require chemotherapy and/or radiotherapy . Life expectancy least 80 week . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Malabsorption . Severe chronic diarrhea . Inadequate oral intake ( unable eat one meal daily chronic nausea , emesis , abdominal/oralesophageal discomfort ) . Any grade 3 bad toxicity . Inability comply study requirement . Concurrent Medication : Excluded : Other investigational agent . Antineoplastic agent . Biologic response modifier ( include interferon ) . Foscarnet . AntiHIV drug study drug . Concurrent Treatment : Excluded : Radiotherapy ( local skin radiotherapy ) . Patients follow prior condition exclude : History nonHodgkin 's lymphoma . Prior Medication : Excluded : Acute therapy opportunistic infection within 14 day prior study entry . Prior HIV proteinase inhibitor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 1996</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Saquinavir</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
</DOC>